The U.S. Food and Drug Administration (FDA) has approved Clear Guide Medical's Clear Guide Scenergy computer-aided instrument guidance system, alongside the company's TP Access Tool with SteriGRID.
The system aims to improve image-guided diagnostic and interventional procedures by leveraging image fusion, instrument recognition and tracking, multimodal markers, and target planning functionalities, the system provides clinicians with a solution for in-suite MR-guided transperineal procedures.
For transperineal biopsy procedures, Clear Guide Scenergy allows clinicians to guide biopsy needles through the perineal skin into the prostate. This decreases the risk of contamination associated with transrectal biopsies that can lead to sepsis, according to the firm.
